Two unspecific peroxygenases (UPO, EC 1.11.2.1) from the basidiomycetous fungi Marasmius rotula and Marasmius wettsteinii oxidized steroids with hydroxyacetyl and hydroxyl functionalities at C17 -such as cortisone, Reichstein's substance S and prednisone -via stepwise oxygenation and final fission of the side chain. The sequential oxidation started with the hydroxylation of the terminal carbon (C21) leading to a stable geminal alcohol (e.g. cortisone 21-gem-diol) and proceeded via a second oxygenation resulting in the corresponding α-ketocarboxylic acid (e.g. cortisone 21-oic acid). The latter decomposed under formation of adrenosterone (4-androstene-3,11,17-trione) as well as formic acid and carbonic acid (that is in equilibrium with carbon dioxide); fission products comprising two carbon atoms such as glycolic acid or glyoxylic acid were not detected. Protein models based on the crystal structure data of MroUPO (Marasmius rotula unspecific peroxygenase) revealed that the bulky cortisone molecule suitably fits into the enzyme's access channel, which enables the heme iron to come in close contact to the carbons (C21, C20) of the steroidal side chain. ICP-MS analysis of purified MroUPO confirmed the presence of magnesium supposedly stabilizing the porphyrin ring system.
Introduction
Steroidal compounds influence animals and humans in various ways [1, 2] . They comprise several biologically active classes of substances such as bile acids, cardio-active drugs (cardiotonics), steroid sapogenins, steroid alkaloids as well as sexual and corticosteroidal hormones [3] . As hormones, they regulate metabolic and ontogenetic processes in humans from fetal life to adulthood. Because of their biological effects, steroids are not only of general scientific interest but also of medical relevance, not least with respect to pharmaceutical applications. In animals including humans, steroids are made from lanosterol that derives from cyclization of the triterpene squalene, which for its part is a product of the mevalonate pathway [4] . One group of pharmaceutically relevant steroids are C21 hormones (pregnane core), which include gluco-and mineralocorticoids produced in the adrenal cortex as well as their precursor progesterone. The latter can be transformed via hydroxylation to 17α-hydroxy progesterone and subsequent side chain removal or C21 hydroxylation to androstenedione and 11-deoxycortisol (Reichstein's substance S), respectively; the former is the direct precursor of the male sexual hormone testosterone and the latter of the glucocorticoid cortisol. Both Reichstein's substance S and androstenedione are important intermediates in industrial steroid syntheses.
Steroids used for therapeutic or other pharmaceutical purposes are largely products of partial synthesis starting from animal cholesterol or herbal phytosterols or sapogenins. The addition, removal and modification of functional groups to, from and at these starting materials is of central importance when producing the wide variety of steroidal drugs. These modifications are achieved using conventional organic synthesis and/or microbial whole-cell biotransformations [5, 6] . Cytochrome P450 enzymes (P450s, CYPs) are the key biocatalysts of steroid biotransformation and catalyze hydroxylation, epoxidation, aromatization and side chain removal [2] . Such reactions are integral part of steroid biosynthesis pathways in humans and animals (see above) and some of them can be also found in microorganisms (fungi, bacteria); typically in form of single transformations with often unknown function for the microbes (e.g. 11α-, 11β-and 16α-hydroxylation by Bacillus, Mycobacterium, Curvularia or Cunninghamella) [6, 7] . However, microbial systems do not mimic all relevant human steroid transformations. Thus side-chain removal (CeC bond cleavage) from progesterone or pregnenolone is exclusively accomplished by vertebrate CYP17A1 (also known as a 17α-hydroxylase/17,20-lyase). It proceeds through two intrinsic reactions: in the first one, the enzyme hydroxylates the 17α-position and in the second reaction, it cleaves the CeC bond between C17 and C20 in a lyase-like reaction resulting in the release of acetate [8] . To our best knowledge, however, steroids hydroxylated in position C21 such as Reichstein's substance S, cortisol or cortisone are not subject of C-C cleavage by CYP17A1 or any microbial P450. Since, on the other hand, Reichstein's substance S is a key precursor in industrial steroid syntheses [9] , it would be worthwhile to have a catalyst that selectively removes the respective hydroxyacetyl moiety to form the corresponding keto-derivatives (17-ones).
Unspecific peroxygenase (UPO, EC 1.11.2.1) is a secreted fungal enzyme type that efficiently transfers oxygen from peroxides (R-OOH) to diverse substrates including unactivated hydrocarbons [10] . Literally, such enzymes strictly follow the peroxide "shunt" pathway of P450s and in this context, they can reach total turnovers numbers of 10 4 to almost 10 6 for oxygen transfer reactions [11] [12] [13] . As P450s, UPO enzymes are heme-thiolate proteins but they do not share any sequence homology with them. Highest sequence homology has been ascertained to fungal chloroperoxidase (CPO, EC 1.11.1.6) that is actually a UPO with strong halide oxidation activity [14] . Among the UPO-catalyzed reactions are hydroxylations, epoxidations, O-and N-dealkylations, oxidations of organic hetero atoms and bromide as well as one-electron oxidations. Their catalytic cycle involves formation of a highly reactive oxoferryl intermediate (compound I) and a protonated basic compound II (oxoferryl hydroxide) that are the active oxygen species in hydroxylation reactions [15, 16] . Crystal structure of the UPO from Agrocybe aegerita (AaeUPO) was solved and has given first insights into the molecular organization of this exceptional peroxidase type [17, 18] .
Here we report two UPOs from the mushrooms Marasmius rotula (MroUPO) [19] and Marasmius wettsteinii (MweUPO, novel wild-type UPO first described herein), which catalyze the selective deacylation of 17α,21-dihydroxycorticosteroids. To our best knowledge, this reaction has not been reported so far for any microbial P450 and represents a new reaction type for UPOs.
Materials and methods

Chemicals
Formic acid (pro analysis) and acetonitrile (ACN, gradient grade for liquid chromatography) were purchased from VWR (Darmstadt, Germany). All other chemicals including cortisone (S I), prednisone (S II), Reichstein's substance S (S III), and adrenosterone (P III) were obtained from Sigma-Aldrich GmbH (Schnelldorf, Germany) in the highest available purity.
Enzyme preparation and characterization
The extracellular peroxygenases from the basidiomycetous fungi Agrocybe aegerita (AaeUPO; main isoform, 46 kDa) and Marasmius rotula (MroUPO; main isoform, 32 kDa denaturated and 58 kDa native) were produced and purified as described previously [19, 20] . The enzyme preparations were homogeneous according to sodium dodecyl polyacrylamide gel electrophoresis (SDS-PAGE) and analytical high performance liquid chromatography-size exclusion chromatography (HPLC-SEC). The specific activities of the AaeUPO and MroUPO preparations were 99.6 U mg −1 and 26.0 U mg
, respectively. One unit (1 U) corresponds to the oxidation of 1 μmol of veratryl alcohol (3,4-dimethoxybenzyl alcohol) to veratraldehyde (3,4-dimethoxybenzaldehyde) in 1 min at 23°C [20] ; activity measurements were performed in 50 mM sodium phosphate buffer at pH 7.0 (AaeUPO) or 5.5 (MroUPO and MweUPO).
A novel wild-type peroxygenase was produced with Marasmius wettsteinii (MweUPO) strain 582 deposited at the culture collection of the International Institute Zittau (Technical University of Dresden, Germany) and at DSMZ Braunschweig (Deutsche Stammsammlung für Mikroorganismen und Zellkulturen, Germany) under DSM 106021. The fungus was isolated from fruiting bodies growing on spruce needle litter (Picea abies) near the Kottmar mountain in East Saxony (Germany) in September 2015 (more information on the fungal species is given in the Supplemental Information section). Stock cultures were maintained in culture slants on 2% malt extract agar at 4°C in the dark. For enzyme production, the content of a completely overgrown agar-plate was homogenized in 80 mL sterile tap water and used for the inoculation of liquid cultures (5% vol/vol of the suspension). Submerged cultivation was performed in 500-mL Erlenmeyer flasks containing 200 mL of a complex liquid medium according to Gröbe et al. [19] on a rotary shaker (120 rpm, at 23°C). The time course of MweUPO production is shown in Fig. S1 . Fungal cultures were harvested after three weeks when the UPO activity had reached approximately 2500 U L −1
. Crude extracts of concentrated culture liquid contained at least five isoforms of MweUPO. The major isoform was isolated via different steps of fast protein liquid chromatography (FPLC) and had a final specific activity of 37.5 U mg ; the corresponding purification table is given in Table  S1 . Homogeneity of the final MweUPO preparation was proven by SDS-PAGE and HPLC-SEC and compared to MroUPO and AaeUPO ( Fig. S2  and S3 ). Molecular mass of the native enzyme was 62 kDa (determined by HPLC-SEC; Fig. S2 ) and 32.5 kDa according to denaturing SDS-PAGE (Fig. S3 ) indicating, as in the case of MroUPO, a physiological dimer [21] . HPLC-SEC of purified MweUPO was carried out using an Agilent Series 1200 instrument equipped with a diode array detector (Agilent Technologies Deutschland GmbH, Waldbronn, Germany) and a Yarra 3 μ SEC-2000 column (300 × 7.8 mm, Phenomenex, Aschaffenburg, Germany). Separation of UPO proteins was achieved at 25°C under isocratic conditions (flow rate 1 mL min −1 ) with sodium acetate/sodium chloride (50 mM/100 mM, pH 6.9) as eluent. Calibration occurred with a gel filtration low-molecular weight calibration kit from GE Healthcare (Munich, Germany). SDS-PAGE was performed as described previously [22] .
Enzymatic reaction setup
Typical reaction set-ups (0.2-1.0 mL) contained UPO protein (1.0-2.0 U mL ) of purified MroUPO, 80 mg of the substrate (S I cortisone, S II prednisone or S III Reichstein's substance S; chemical structures are shown in Fig. 1 ), 2.5 mL of ACN (final concentration of 5% vo/vol) and potassium phosphate buffer (50 mM, pH 5.5). The reaction was started by the addition of hydrogen peroxide (H 2 O 2 , 1 mM) and repeated every 6 min over 1 h (final concentration 10 mM).
Analytical methods
HPLC-MS method I (for standard reactions)
Products of enzymatic syntheses were analyzed by high performance liquid chromatography (HPLC) using an Agilent Series 1200 instrument equipped with a diode array detector and an electrospray ionization mass spectrometer (ESI-MS) (Agilent Technologies Deutschland GmbH, Waldbronn, Germany). Unless otherwise stated, reverse phased chromatography on a Luna C18 column (2 mm diameter by 250 mm length, 3 μm particle size, Phenomenex, Aschaffenburg, Germany) was used. Column was eluted at a flow rate of 0.2 mL min −1 and 40°C with aqueous 0.01% vol/vol ammonium formate (pH 3.5)/ACN, 95:5 for 5 min, followed by a 15-min linear gradient to 100% ACN. Mass spectrometric measurements were made in positive or negative ESI mode in a mass range from 70 to 900, step size 0.1, drying gas temperature 350°C, capillary voltage 4000 V for positive mode and 5500 V for negative mode. Reaction products were identified relative to authentic standards, based on their retention times, UV absorption spectra, and mass spectral data (
HPLC-MS method II
Additional analyses were performed using a Kinetex C18 column (2 mm diameter by 250 mm length, 5 μm particle size, Phenomenex), which was eluted with a flow rate of 1 mL min −1 at 40°C with aqueous 0.01% vol/vol ammonium formate (pH 3.5)/ACN, 95:5 for 2 min, followed by a 12-min linear gradient to 100% ACN. MS parameters were the same as described under method I.
HPLC-MS method III
Kinetic studies on the conversion of cortisone by MroUPO and MweUPO were carried out by applying a more rapid HPLC method. Respective samples were analyzed using a Phenomenex Kinetex PhenylHexyl column (2.6 μm particle size, 150 × 2.1 mm). The flow rate was 0.4 mL min −1 and the temperature set to 40°C. The following gradient of 0.01 vol% ammonium formate (pH 3.2) and ACN was performed: 0-0.2 min 20% ACN followed by a linear gradient to 65% ACN (0.2-10 min) and to 85% (10-12 min). The MS parameters were the same as in method I.
Ion chromatography (IC) method for organic acids
Organic acids were analyzed by IC using a Dionex Series ICS1100 system (Thermo Fisher GmbH, Idstein, Germany) fitted with an IonPac® ICE-AS1 column (4 mm diameter by 250 mm length, Dionex, Germering, Germany). The column was eluted at 30°C and 1.6 mL min
with an aqueous perfluorobutyric acid solution (1 mM) over 20 min. Products were identified relative to the authentic standards by their retention times.
HPLC-UV method for organic acids. Analyses were performed using a Rezex™ ROA-Organic Acid H + (8%) column (7.8 mm diameter by 300 mm length, Phenomenex). The column was eluted at 50°C and 0.5 mL min −1 with an aqueous sulfuric acid solution (0.005 N) over 25 min. Acids were recorded at 210 nm and identified relative to authentic standards by their retention times.
Product isolation
Products of enzymatic steroid oxidation were separated and purified by preparative HPLC using a 1260 Infinity Agilent system (Agilent Technologies Deutschland GmbH) equipped with a Kinetex C18 column (Axia packed, 21.2 mm diameter by 150 mm length, 5 μm particle size, Phenomenex), which was eluted at 20 mL min −1 and room temperature with water/ACN 70:30 for 1 min under isocratic conditions, followed by a 5-min linear gradient to 70% ACN and a 1.5-min gradient to 100% CAN, which was hold for 0.5 min and then set to 30% ACN within 1 min. Eluting peaks (detected at 240 nm) were sampled with an Infinity fraction collector (fraction collector; preparative scale, G1364B, Agilent Technologies Deutschland GmbH). The purity of isolated products was checked by analytical HPLC-MS (method I above).
NMR spectroscopy experimental conditions
2.65 mg of P I and 0.5 mg of P II were transferred into capillary NMR tubes of 2.5 × 100 mm in 150 μL dimethylsulfoxide-d6 (99.8%, Deutero, Kastellaun, Germany). Proton, COSY (correlated spectroscopy), HSQC (heteronuclear single quantum coherence) and HMBC (heteronuclear multiple bond correlation) spectra were recorded on a Bruker Avance 500 MHz spectrometer equipped with a 2.5 mm selective inverse SEI probe (Bruker, Rheinstetten, Germany). For technical reasons, some HMBC spectra had to be recorded on a Bruker Avance III 600 MHz instrument equipped with a 1.7 mm inverse SEI probe (part of the sample was transferred in to 1.7 × 100 mm microtubes). For chemical shift prediction, the ACD/C + H NMR predictors, release 2015, pack2, from ACDlabs (Toronto, Ontario, Canada) were used.
Precipitation of carbon dioxide with barium hydroxide
Carbon dioxide (CO 2 ) formation in the course of side chain removal from cortisone was qualitatively proved in a separate experiment. Two vials filled with 1 mL of saturated barium hydroxide [Ba(OH) 2 ] were connected via silicon tubes with two further vials containing the reaction mixture with MroUPO (active sample) or a control without enzyme (Fig. S7) . The reaction occurred under helium atmosphere. Before starting the reaction, the intrinsic CO 2 was stripped by flushing with helium, over 10 min. Afterwards the reaction was started as described 
Determination of the metal content in MroUPO
Purified MroUPO was washed with deionized water resulting in a final protein concentration of 4 μM determined by a standard Bradford assay. Inductively coupled plasma optical emission spectroscopy (ICP-OES) and ICP mass spectrometry (ICP-MS) were performed on an Optima 3000 system and an Elas DRC-e device (both PerkinElmer Inc., MA, USA), respectively. The OES-system was calibrated with the 'ICP multi-element standard solution IV' (Mg, K, Ca, Mn, Fe, Cu) as well as the 'phosphorus ICP standard' (both Merck, Darmstadt, Germany) in ) of the 'ICP multi-element standard solution VI' (V, Mn, Fe, Co, Cu; Merck, Darmstadt, Germany) were used to calibrate the MS unit.
Crystal structure and 3D-modelling
The crystal structure data of MroUPO have been made available recently (protein data bank entries 5FUJ and 5FUK). Based on them, first structures were published indicating that MroUPO is a dimeric protein with a relatively wide heme access channel [21] . Cortisone was docked into the MroUPO active site cleft using the open-source program AutoDock Vina, version 1.1.2 [23] . The MroUPO structure (PDB 5FUJ) and the cortisone molecule (3D conformation obtained from PubChem [24] , CID 222786; 4 rotatable bonds) were prepared for docking in AutoDockTools [25] , version 1.5.6. In order to define the active site of MroUPO, cortisone as substrate was first placed manually at the entrance of the protein's binding pocket using PyMOL (The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC). The grid box was centered at x: −10.607, y: −17.81 and z: −28.584 with sizes of 20.25, 16.5, and 9.75 Å, respectively. Exhaustiveness was tested between 8 and 100. No more than twenty output poses (energy range 5 kcal mol −1 with a maximum number of 30 for binding modes) were generated. In separated runs, the best three models occurred repeatedly. The docking model with highest affinity (−8.3 kcal mol −1 ) in all runs shows close proximity of cortisone C21 to heme iron (4.4 Å) and is shown in Fig. 6 .
Results
Enzymatic conversion of cortisone (S I)
Both MroUPO and MweUPO were found to be capable of converting , respectively. These TON were limited by the limited amount of H 2 O 2 gently and continuously supplied via a syringe pump, which would theoretically entail a maximum TON of 6.9 min −1 under the conditions applied (co-substrate limitation to prevent heme damage).
The first product that appeared within 20 min had a molecular mass of 376 (P I; m/z M + H + : 377) indicating a hydroxylated metabolite (Fig. 2) . 20 min later, a second product was detectable with a molecular mass of 374 (P II; m/z M + H + : 375) probably representing an oxidation product of P I. P II showed an unusual peak shape (tailing) in the HPLC elution profile that is characteristic for keto-enol tautomerism or the presence of an aldehyde hydrate (that is in equilibrium with the corresponding free aldehyde). After 80 min, the formation of P I had reached its maximum, while the peak of P II still increased. 160 min after starting the reaction, a third product (P III) emerged with a smaller mass of 300 (m/z M + H + : 301); it was identified by means of an authentic standard as adrenosterone and simultaneously, P II started to decrease (Fig. 2) . At the end of the experiment (after 220 min), only 20% of P II's maximum peak area remained, while P III reached a maximum concentration of 359 and 347 μM in the case of MroUPO and MweUPO, respectively. The respective results are summarized in Figs. 2, 3 and S5. Compared to the Marasmius UPOs, AaeUPO merely converted S I to negligible extent (< 1%), which resulted in traces of P II and P III (Fig. 3) .
The observed HPLC peak pattern and the almost identical UV spectra of substrate and products, caused by the unchanged chromophore (double bonds in the steroidal A ring), prompted us to analyze the MS data more in detail to identify possibly hidden additional products. Indeed, the hint of an additional mass eluting at the same time as the substrate (S I) was observed. Therefore, the HPLC method was modified and improved (among others by changing the stationary phase). Then, we analyzed the extracted ion counts of the respective MS data (given in Fig. S5 for MweUPO) again and found a fourth product (P IV; most likely 17-hydroxy-3,11-dioxoandrost-4-ene-17-carboxylic acid) with a molecular mass of 346 (m/z M + H + : 347). Fig. S5 displays a further metabolite (P V) with a mass of 316 (m/z: 317 M + H + ), probably a hydroxylation product of the fission product P III. Both P IV and P V were only detectable in traces and could not be quantified because of lacking standards; thus changes in their concentration were deduced from the corresponding peak areas (based on UV-absorption).
NMR spectroscopic analysis of the products P I and P II
Particular efforts were made to unambitiously identify the products P I, P II and P III by 13 C/ 1 H NMR spectroscopy. The NMR assignment of P I was based on the analysis of the side chain resonances in conjunction with chemical shift prediction and comparison to cortisone reference spectra (Table S2 ). In the side chain, a CH signal at 84.1/ 5.39 ppm indicating an alcoholic substitution was observed along with a carbonyl function at 207.0 ppm. Two possible keto-enol tautomeric structures were considered. The COSY showed that the CH signal at 84.1/5.39 ppm couples to two OH doublets at 6.12 and 6.36 ppm, respectively. Moreover, we observed HMBC correlations between the carbonyl resonance at 207.0 ppm and the CH proton at 5.39 ppm and the OH protons at 6.12 and 6.36 ppm. Furthermore, we observed HMBC couplings between the carbon at 84.05 ppm and two OH (6.12 and 6.36 ppm). This clearly establishes P I to be structure 1 (cortisone 21-gem-diol) given in Fig. 4 , along with an additional minor species in the same sample (P Ia accounting for approximately 14%). The structure of P Ia being the hydrate of an aldehyde prompted us to further inspect the heteronuclear spectra: Fig. 4 shows the aldehyde section of the respective HMBC spectrum. A correlation between a CH at 9.66/ 195. (Fig. 4) .
For the second metabolite (Table S3) , P II, we suggest the structure of a carboxylic acid (cortisone 21-oic acid) given in Fig. 5 . Inspection of the proton, COSY and HSQC spectra showed that the sterane scaffold resonances were unchanged, while side chain CH resonances could not be observed. An additional OH proton resonance appeared at 7.09 ppm (integral one proton). Unfortunately, the sample's concentration was too low to observe the carbonyl 13 C signals, through neither direct 13 C NMR nor HMBC. P III was the major product at the end of the reaction (with about 70% yield) and identified as adrenosterone (4-androst-ene-3,11,17-trione) by means of an authentic standard. As the corresponding fission products, we found traces of formic acid (HCOOH) and carbonic acid (H 2 CO 3 ) by ion chromatography (IC; data not shown) and HPLC with UV detection (Fig. S6) . In addition, the formation of carbon dioxide (that is in equilibrium with carbonic acid and bicarbonate) in the reaction solution was confirmed by the formation of a whitish smear of precipitating barium carbonate (BaCO 3 ) when gaseous substances formed were stripped from the reaction solution and flushed through a barium hydroxide solution (Fig. S7) . Unexpectedly, glycolic acid (HO-H 2 C-COOH) and glyoxylic acid (OHC-COOH) -the supposed fission products -were not detectable in the reaction solutions. On the other hand, glycolic acid was found to be a substrate of MroUPO that was rapidly oxidized into glyoxylic acid, formic acid and carbon dioxide as proved by HPLC-UV, IC and BaCO 3 formation (data not shown).
The residual UPO activity in the reaction solution followed an interesting biphasic time course (both for MroUPO and MweUPO). As long as S I and P I were present in the reaction solution, the enzyme activity remained rather stable, however, after their consumption (between 120 and 140 min), the activity strongly decreased, probably caused by unfavorable catalysis during conversion of P II into the final product P III (Fig. 2) .
The conversion of prednisone (S II) and Reichstein's substance S (S III) by MroUPO and MweUPO gave similar results as for S I. Both compounds were converted in three ways following the mass changes Δm/z = +16, Δm/z = +14 and Δm/z = −60. The latter mass indicates that the last step was again a side chain removal resulting in the formation of 4-androsten-3,17-dione and 1,4-androstadien-3,11,17-trione, respectively (data not shown). AaeUPO oxidized S II and S III to negligible extent (< 1%) with traces of S (−60) as sole product.
Structure and metal content of MroUPO
Based on the recently published coordinates and first crystal structure of MroUPO [21] , we performed a docking analysis using cortisone (substrate S I) as ligand and MroUPO as receptor with the open-source program AutoDock Vina. Corresponding Fig. 6 shows that the corticosteroid molecule almost perfectly fits into the active site of MroUPO, while exposing the side chain to be removed towards the reactive heme center. In the computed model, cortisone's C21 appears in close proximity to the heme iron (4 Å). The binding pocket virtually consists just of aliphatic residues (leucine, Leu; isoleucine, Ile) and contains merely one aromatic residue (phenylalanine, Phe). One polar serine well as the corresponding dehydrated aldehyde P Ia being in equilibrium with P I. Bottom: HMBC spectrum of P I indicating the presence of the corresponding free aldehyde (P Ia).
residue (Ser156) is also found in this pocket; however, this residue does seemingly not form polar contacts to cortisone in the best fitting docking models. The keto groups at C3 and C11 of cortisone lie outside the binding pocket. The hydroxyl group at C17 as well as the keto group at C20 do not have polar contacts to amino acid residues of MroUPO. In the second best fitting model (with correct orientation of the hydroxyacetyl group to heme but slightly less binding affinity of −8.2 kcal mol −1 ), these both oxygen functionalities build intra-molecular contacts. The hydrogen of the hydroxyl group at C21 can build a polar contact to the hydroxyl-oxygen of the carboxylic group of a glutamate (Glu157, the distal acid-base catalyst) and thereby stabilizes correct substrate binding. Since magnesium (Mg) had been found in the crystal structure of AaeUPO [18] , we checked whether MroUPO does also contain this probably stabilizing metal. ICP-MS and ICP-OES analyses in fact revealed that Mg was along iron (Fe) the most abundant metal in purified MroUPO. Its amount corresponded to nearly one mol Mg per UPO molecule (Table S4 ). In contrast, the concentration of other metals, including manganese (Mn) and calcium (Ca) reported to be present in other heme peroxidases [26] [27] [28] , were noticeably lower.
Discussion
Two UPOs from the mushroom genus Marasmius (MroUPO, MweUPO) were found to convert corticosteroids with hydroxyacetyl (-CO-CH 2 OH) and alcohol (-OH) functionalities at C17 via stepwise oxygenation/oxidation and final removal of the side chain (C-C cleavage, deacylation). In contrast, the model enzyme AaeUPO known to oxidize diverse other substrates, failed in catalyzing this reaction [10, 29] . In a previous study, three UPOs including AaeUPO and MroUPO were shown to hydroxylate steroids with longer side chains (with 8-10 carbon atoms) such as cholesterol, ergosterol and sitosterol preferably at tertiary C25, their scission, however, was not observed [30] . Another UPO from the ascomycetous mold Chaetomium globosum (CglUPO) has recently been demonstrated to selectively epoxidize (at 4,5-position) testosterone that is neither a substrate of MroUPO nor of AaeUPO [31] .
The ability of MroUPO and MweUPO to convert bulky substrates such as cortisone (S I), prednisone (S II) and Reichstein's substance S (S III) can be attributed to the size and molecular architecture of the enzymes' active site. Both Marasmius enzymes belong to the cluster (subfamily) of "short" UPOs whereas AaeUPO is a "long" UPO that differs in several features from the former ones [29] . Thus, the heme access channel of MroUPO is about 4 Å shorter and up to 5 Å wider than that of AaeUPO. Furthermore, the hydrophobic amino acid residues flanking the heme access channel are different. While AaeUPO contains nine rigid Phe and one Tyr forming a rather narrow "carafe-shaped" heme channel (Fig. 7B ), MroUPO's heme channel comprises only one Phe but ten more flexible aliphatic amino acids (1 Ala, 2 Leu, 7 Ile; Fig. 6 ) and thus forms a rather open and symmetric frustum (Fig. 7A ) [18] . These structural differences may explain, which is why MroUPO (and also MweUPO that shares > 90% sequence identity with MroUPO, unpublished result) harbor and convert bulky substrates such as corticosteroids whereas AaeUPO cannot (Fig. 6) .
A plausible reaction sequence involving the stepwise oxygenation and final deacylation of cortisone-and related substrates (S I-III) by MroUPO (and respectively by MweUPO) can be described as follows. In the first step, the enzymes hydroxylates the position C21 in the side chain by means of H 2 O 2 (peroxygenation) resulting in the formation of P I that is a geminal alcohol (21-gem-diol, aldehyde hydrate) being in equilibrium with the corresponding free aldehyde (cortisone 21-al, P Ia) (Fig. 8) . A similar reaction was observed during the oxidation of 5-hydroxymethylfurfural (HMF) by AaeUPO (or aryl alcohol oxidase) leading to the corresponding dialdehyde (diformylfurane), about 50% of which was in equilibrium with its stable hydrate (gem-diol detectable by MS) [32, 33] . In the next step, the Marasmius UPOs catalyze a second hydroxylation leading to the corresponding α-ketocarboxylic acid P II (corstisone 21-oic acid). However, so evident the structure of P II is (compare respective NMR data), so uncertain is the exact point of enzymatic attack at P I. This is due to the different tautomeric and hydrated forms of P I. Theoretically -in addition to P I and P Ia (the latter detected by NMR, Table S2 ) -two further tautomeric structures, a 21-endiol and an α-hydroxy-21-oic acid, are conceivable; all of them would be substrates of Marasmius UPOs and converted into P II. In our opinion, the most probable route may proceed via the hydroxylation of the free aldehyde (P Ia; Fig. 8 ). This reaction type via abstraction of hydrogen (C-H abstraction) and OH-rebound has been reported for various UPO substrates including aromatic (e.g. benzaldehyde) and aliphatic (n-alkanals) aldehydes, which are oxidized into the corresponding carboxylic acids (e.g. benzoic acid and n-alkanoicfatty acids, respectively) [34, 35] . An alternative route may start from the 21-gem-diol and proceed via an additional hydroxylation at C21 to form a putative 21-gem-triol that spontaneously dehydrates under formation of the 21-oic acid, Fig. 8) . A third variant may follow the hydroxylation of the α-hydroxy-21-oic acid tautomer of P I to give the corresponding 20-gem-diol that dehydrates to P II; eventually, the epoxidation of the tautomeric 21-enediol could contribute to P I conversion as well (not shown). Corticosterone with the same hydroxyacetyl moiety as cortisone (but lacking OH at C17) was reported to be analogously oxidized by a panel of liver CYPs (especially of the CYP3A and CYP4A subfamilies), involving 21-gemdiol, 21-gem-triol and 21-al intermediates and resulting in the final formation of the corresponding 21-oic acid [36] .
The last step in the conversion of corticosteroids by Marasmius UPOs proceeds via the removal of the side chain, which results, in the case of P II, in the appearance of adrenosterone (17-one, P III) (Fig. 9) . Although the formation of the latter compound was unambiguously demonstrated (by an authentic standard), it is the most difficult-to-explain step of the reaction sequence [37] (Fig. 9) . Taking into consideration the existing knowledge on steroidal side-chain removal by 17α-hydroxylase/C17,20-lyase (CYP17A1) [8] , recently described UPO-catalyzed fatty acid decarboxylation [21] and existing knowledge on chemical decarboxylation of α-ketoacids by hydrogen peroxide [38, 39] , it appears to be plausible that P II undergoes both enzymatic and chemical oxidation in the course of side-chain removal (Fig. 9) . Thus, a lyase-like reaction resulting in CeC bond scission between C17 and C20, release of glyoxylic acid (that is immediately oxidized/cleaved by UPO to formic acid and CO 2 /carbonic acid) and the formation of a new double bond at C17 (carbonyl, P III) is as conceivable as the peroxide-driven oxidation of P II (caused by the peroxo-anion/HOO -at the pH used [38] ), which results via a peroxo-intermediate in the release of CO 2 and a C17-ol/C17-oic acid derivative (P IV, the mass of which fits to the detected m/z [H + ] of 347); in a final spontaneous step, less stable P IV may decay to formic acid and P III (17-one) (Fig. 9) . Whether a compound-0-like UPO-intermediate (i.e. a bound peroxo-anion-heme species) is involved as proposed for the C17,20-lyase reaction of CYP17A1 remains unclear [40] . The rapid inactivation of Marasmius UPOs during the obviously unfavorable conversion of P II into P III may support this assumption (Fig. 2) . The presence of equimolar amounts of magnesium (Mg 2+ ) in purified MroUPO confirms the importance of this metal as structural element in UPO proteins. Strong indication of its presence were also found in the crystal structure of AaeUPO and it was detected by ICP-MS/OES analysis in highly pure preparations of the enzyme [18] . It may stabilize the porphyrin ring system that is under permanent ring strain. Interestingly, the Mg ion sits at the same position as Mn 2+ in manganese peroxidase (MnP, EC 1.11.13.1) [41] . In both cases, the metals are chelated by conserved acidic amino acid residues (Glu, Asp) and the heme propionate [18, 41] . The presence of manganese was proposed for CPO based on its crystal structure (but without appropriate metal analysis) [26] . However, when considering the function of Mn in MnP [42] and the almost identical covalent atomic radiuses of Mn
2+
(1.39 Å) and Mg 2+ (1.41 Å) [43] , it is more conceivable that redoxinactive Mg 2+ is present in CPO representing a halide-oxidizing UPO [14] .
Conclusions
After recently reported fatty acid shortening by MroUPO [21] , steroidal side-chain removal is the second example of a C-C cleaving Fig. 7 . Tangential cross sections through crystal structure-based 3D-models of MroUPO and AaeUPO; the former (A) has a rather open and symmetric frustumlike heme access channel whereas that of the latter (B) is narrower and "carafeshaped". reaction (deacylation) catalyzed by this enzyme type. Thereby another prototypical reaction of P450s (in this case lyase-activity of CYP17A1) with physiological and biotechnological relevance could be ascertained for a secreted fungal peroxygenase. Future studies will have to elucidate the role of UPO compound 0 and whether other fungal UPOs (of which > 4000 sequences are known so far) may catalyze similar reactions without loosing their activity during the scission process. 
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The authors declare that they have no conflict of interest. Fig. 8 . Postulated reactions involved in the side chain oxidation of S I (cortisone) by MroUPO and MweUPO. First hydroxylation at C21 results in P I (cortisone 21-gem-diol, identified by NMR) that is in equilibrium with the corresponding free aldehyde P Ia (cortisone 21-al, also identified by NMR). Both P I and P Ia can be subject of a second hydroxylation at C21 resulting in the direct formation of P II (cortisone 21-oic acid, detected by NMR) or in putative cortisone gem-triol # that is in equilibrium with P II. Fig. 9 . Possible reaction sequences explaining the side chain removal from P II (cortisone 21-oic acid) by MroUPO and MweUPO. 1) A lyase-like activity of UPO similar to that described in [44] may cleave the CeC bond between C17 and C20 resulting in P III (adrenosterone, identified by an authentic standard) and putative glyoxylic acid that can be cleaved by UPO into formic acid and carbonic acid/carbon dioxide (as demonstrated by authentic standards and barium carbonate precipitation). 2) P II may also chemically react with H 2 O 2 to form a tetrahedral intermediate [38] that decomposes to carbon dioxide and P IV (17-hydroxy-3,11-dioxoandrost-4-ene-17-carboxylic acid, as indicated by mass data).
